Atlas Trials

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Clinical trial NCT06409195 · UNKNOWN

Trial details

NCT number
NCT06409195
Sponsor
DermBiont, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Melanoma Skin Cancers
Start date
2024-03-25
Primary completion
2024-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.